Navigation Links
EraGen cystic fibrosis test to be distributed worldwide through Bayer

EraGen Biosciences in Madison landed an exclusive worldwide distribution agreement for its new cystic fibrosis assay, MultiCode PLx, to the Diagnostics Division of Bayer HealthCare LLC.

The new assay can be automated for mutation carrier screening and neonatal and newborn testing. The agreement also allows Bayer Hea......

Full article >>> automation, decreased hands-on time, and less involvement of very skilled workers."

This latest agreement is but the next time in a continuing relationship between the two companies: Bayer has incorporated EraGen's core technology into its own proprietary applications for HIV and hepatitis tests. Those applications have FDA approval and have been on the market for about five years.

Full article >>>
'"/> By Lincoln Brunner 05/18/05

Related biology technology :

1. EraGen set to highlight diagnostic products at BIO
2. EraGen diagnostic passes UW tests, could quickly detect bird flu
3. EraGen lands $12 million venture round
4. EraGen gets $250,000 state loan to revamp manufacturing facility
5. EraGen strikes big distribution deal; Berbee buys again
6. EraGens SARS test validated by Chinese agency
7. EraGen collaborates with Emory University on HIV detection system
8. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
9. Promega and EraGen sign technology licensing agreement
10. EraGens Revolutionary Genomic-Based Technologies
11. EraGen Expands in Japan
Post Your Comments:

(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):